JPMorgan Funds - Thematics - Genetic Therapies I2 (acc) - USD/  LU2112815027  /

Fonds
NAV11/06/2024 Chg.+0.1300 Type of yield Investment Focus Investment company
72.3000USD +0.18% reinvestment Equity Worldwide JPMorgan AM (EU)